These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 4180646)
41. [Results of SPI, SPG and combination of radiotherapy in the management of certain tumors]. Uzel R; Adali I; Civelekoğlu E Turk Tip Cemiy Mecm; 1967 Feb; 33(2):106-16. PubMed ID: 6040938 [No Abstract] [Full Text] [Related]
42. [Internal treatment of carcinoma with the cytostatic Proresid]. Schärtl W Munch Med Wochenschr; 1966 Jan; 108(2):112-4. PubMed ID: 5341497 [No Abstract] [Full Text] [Related]
43. [Clinical use of podophyllinic acid ethylhydrazide (SP-I) and podophyllotoxin-beta-o-benzyliden-glucoside (SP-G) in malignant urologic tumors]. Aso Y; Hoshi Y; Okada K; Koiso K; Murahashi I Gan No Rinsho; 1969 May; 15(5):453-7. PubMed ID: 5387577 [No Abstract] [Full Text] [Related]
44. [Combination of radiotherapy of carcinoma of the cervix with cobalt-60-radium-gamma-irradiation and the use of the cytostatic drug SP-I/SP-G]. Paeschke KD Strahlentherapie; 1965 Jun; 127(2):192-7. PubMed ID: 5834412 [No Abstract] [Full Text] [Related]
45. [Comparative results of massive endoxan stoss therapy and treatment of malignant tumors with proresid]. Gebhardt KH; Becher R Med Welt; 1967 Jul; 30():1705-7. PubMed ID: 5616405 [No Abstract] [Full Text] [Related]
46. [Observations on patients treated with proresid]. Bogdanowski T; Lobzowski J; Mroczka A Wiad Lek; 1971 May; 24(9):893-6. PubMed ID: 5579369 [No Abstract] [Full Text] [Related]
51. [Progress in the field of antineoplastic agents]. Koyama Y; Takemasa Y Naika; 1967 Jun; 19(6):1307-13. PubMed ID: 4867770 [No Abstract] [Full Text] [Related]
52. [The chemotherapy of cancer]. Clément F Praxis; 1967 Dec; 56(49):1664-71. PubMed ID: 4972131 [No Abstract] [Full Text] [Related]
53. [Evaluation of immunosuppressive therapy with podophyllin derivatives in the treatment of primary chronic polyarthritis]. Szántó L Z Gesamte Inn Med; 1969 May; 24(10):154. PubMed ID: 5807426 [No Abstract] [Full Text] [Related]
54. Human anticancer effect of podophyllum derivatives (SPG and SPI): a preliminary report. Chakravorty RC; Sarkar SK; Sen S; Mukerji B Br J Cancer; 1967 Mar; 21(1):33-9. PubMed ID: 6024514 [No Abstract] [Full Text] [Related]
55. [On a long lasting remission of myelocytic leukemia following cytostatic therapy]. Bross W; Olejak B; Bross T Ther Umsch; 1966 Jul; 23(7):299-302. PubMed ID: 5234434 [No Abstract] [Full Text] [Related]
56. [Observations on the therapy of primary cancer of the lung (sample research on 100 subjects treated)]. Massei V Rass Int Clin Ter; 1967 Jun; 47(12):642-50. PubMed ID: 5607587 [No Abstract] [Full Text] [Related]
57. [On the treatment of malignant tumors with podophyllotoxin derivatives]. Goldschmidt F; Busch W Arch Ohren Nasen Kehlkopfheilkd; 1965; 185(2):815-20. PubMed ID: 5881127 [No Abstract] [Full Text] [Related]
58. Giant condylomata of Buschke and Lowenstein. Weakley DR Arch Dermatol; 1969 Oct; 100(4):488. PubMed ID: 5358115 [No Abstract] [Full Text] [Related]
59. [Tumor-specific effects of substances of the podophyllotoxin and Verrucaria series on the chorioallantoic membrane tumor system]. Rauen HM; Norpoth K Arzneimittelforschung; 1966 Dec; 16(12):1594-600. PubMed ID: 6014933 [No Abstract] [Full Text] [Related]
60. [Cancer of the esophagus: treatment with the cytostatic agents SP-G and SP-I]. Guida Filho B; Mirra AP Rev Paul Med; 1968 Feb; 72(2):49-54. PubMed ID: 5739063 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]